Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation
about
Brd4-independent transcriptional repression function of the papillomavirus e2 proteinsInduction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplificationHuman papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar wartsThe bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latencyAlleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.A compilation of composite regulatory elements affecting gene transcription in vertebratesCCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region.Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.Epidermal differentiation: the bare essentialsVariation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world.Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoterTransient replication of human papillomavirus DNAs.Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distanceA bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factorInfectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.Transcription factor AP2 and its role in epidermal-specific gene expression.A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts.Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 proteinmRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor.Clonal selection for transcriptionally active viral oncogenes during progression to cancer.Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice.
P2860
Q24671845-83978950-8321-4A80-BF1C-EC780A5AD46FQ33724179-9F1A0E1E-6843-4D0B-A5C5-9B22A38C1076Q33905805-4F180876-1605-4041-BB4A-222FC51D1FECQ33932448-5A725335-831C-4134-BCC1-A42AF1612939Q33961239-F9EB2A6F-6EC1-404F-A002-32A36956CC83Q34338679-026BC32C-7E92-417D-B845-7A1E2C4C412FQ34776433-DE195353-12EB-4211-9241-497744EE64A7Q35878106-3D2924DC-589A-4287-982A-9CB49C20D78AQ35899069-93B6415F-CD82-4B87-9988-3E72C3CED71CQ35907341-D76547ED-0226-4D2D-AB17-8BDC9177C1A1Q36224142-7E754082-3E1C-48FB-8348-724C106EFDD1Q36523157-42EA72C6-A3B9-4EE5-9DEF-0305F1154085Q36627345-D4CA76DD-158C-4026-8F7B-F2A1C49498AFQ36636419-F6F124BF-3DF8-401E-BD79-475F3F872301Q36687296-AE6776DF-70A3-4DEF-B83A-0611EDDE3AD4Q36702215-DF2DB0F4-1438-4B42-A1CB-17DAF8A4DC5AQ36722400-B19EDD03-F29C-4590-8E95-BEC93447A2EBQ36793349-0F714026-B490-482D-85CC-108771758721Q36810038-CD6B43A7-BC06-4877-A12B-582AC9F5E3ECQ36820980-0662DA60-EAA2-4025-BCD1-5CFF5A15F51CQ37456675-8B473852-F1D1-43C6-85C9-AED6228B7B7BQ37591852-712A368A-D336-4D7F-81D3-7AAA853066C8Q37606041-59D05ECE-F246-47A5-B7E9-015C42DCE8F3Q38322149-489F15F1-F07C-4647-AE28-3829E991A760Q39877539-225A607F-A1A2-425D-AC09-3287CB7692DAQ40008754-34652AAA-95B6-4D26-ABAB-DFF08A01A50EQ40044601-ADA9E57A-78A6-4F23-8C15-693A8D9E333FQ40065013-6B4DFDFF-36E5-4F2B-8678-A3D7068B9C4CQ40163392-DA4AA3B5-02BA-402B-9B04-590CC1C9122AQ40309052-0F2CA898-E54A-4E0D-848B-B179547322E5Q42483235-C5AD1B74-94E0-412C-A3EF-305032F7A431
P2860
Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Identification of a novel cons ...... us type 11 enhancer regulation
@en
type
label
Identification of a novel cons ...... us type 11 enhancer regulation
@en
prefLabel
Identification of a novel cons ...... us type 11 enhancer regulation
@en
P2093
P2860
P1433
P1476
Identification of a novel cons ...... us type 11 enhancer regulation
@en
P2093
P2860
P304
P407
P577
1989-07-01T00:00:00Z